Similar articles for PMID: 28830717

Year	Number of Results
2000	1
2001	2
2004	2
2005	1
2009	2
2010	3
2011	3
2012	8
2013	13
2014	13
2015	12
2016	20
2017	27
2018	28
2019	19
2020	11
2021	6
2022	7
2024	0

1

Mid-radiotherapy PET/CT for prognostication and detection of early progression in patients with stage III non-small cell lung cancer.

Gensheimer MF, Hong JC, Chang-Halpenny C, Zhu H, Eclov NCW, To J, Murphy JD, Wakelee HA, Neal JW, Le QT, Hara WY, Quon A, Maxim PG, Graves EE, Olson MR, Diehn M, Loo BW Jr. Gensheimer MF, et al. Radiother Oncol. 2017 Nov;125(2):338-343. doi: 10.1016/j.radonc.2017.08.007. Epub 2017 Aug 19. Radiother Oncol. 2017. PMID: 28830717

2

Greater reduction in mid-treatment FDG-PET volume may be associated with worse survival in non-small cell lung cancer.

Kong FS, Li L, Wang W, Campbell J, Waller JL, Piert M, Gross M, Cheng M, Owen D, Stenmark M, Huang KC, Frey KA, Ten Haken RK, Lawrence TS. Kong FS, et al. Radiother Oncol. 2019 Mar;132:241-249. doi: 10.1016/j.radonc.2018.10.006. Epub 2018 Oct 30. Radiother Oncol. 2019. PMID: 30389239 Free PMC article.

3

Prognostic Value of the Volumetric Parameters of Dual-Time-Point ¹⁸F-FDG PET/CT in Non-Small Cell Lung Cancer Treated With Definitive Radiation Therapy.

Okazaki E, Seura H, Hasegawa Y, Okamura T, Fukuda H. Okazaki E, et al. AJR Am J Roentgenol. 2019 Dec;213(6):1366-1373. doi: 10.2214/AJR.19.21376. Epub 2019 Sep 11. AJR Am J Roentgenol. 2019. PMID: 31509426

4

Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.

Zhang H, Wroblewski K, Liao S, Kampalath R, Penney BC, Zhang Y, Pu Y. Zhang H, et al. Acad Radiol. 2013 Jan;20(1):32-40. doi: 10.1016/j.acra.2012.07.002. Epub 2012 Sep 19. Acad Radiol. 2013. PMID: 22999369

5

New positron emission tomography derived parameters as predictive factors for recurrence in resected stage I non-small cell lung cancer.

Melloni G, Gajate AM, Sestini S, Gallivanone F, Bandiera A, Landoni C, Muriana P, Gianolli L, Zannini P. Melloni G, et al. Eur J Surg Oncol. 2013 Nov;39(11):1254-61. doi: 10.1016/j.ejso.2013.07.092. Epub 2013 Aug 13. Eur J Surg Oncol. 2013. PMID: 23948705

6

Prognostic values of mid-radiotherapy ¹⁸F-FDG PET/CT in patients with esophageal cancer.

Kim N, Cho H, Yun M, Park KR, Lee CG. Kim N, et al. Radiat Oncol. 2019 Feb 4;14(1):27. doi: 10.1186/s13014-019-1232-1. Radiat Oncol. 2019. PMID: 30717809 Free PMC article.

7

Optimal FDG PET/CT volumetric parameters for risk stratification in patients with locally advanced non-small cell lung cancer: results from the ACRIN 6668/RTOG 0235 trial.

Salavati A, Duan F, Snyder BS, Wei B, Houshmand S, Khiewvan B, Opanowski A, Simone CB 2nd, Siegel BA, Machtay M, Alavi A. Salavati A, et al. Eur J Nucl Med Mol Imaging. 2017 Nov;44(12):1969-1983. doi: 10.1007/s00259-017-3753-x. Epub 2017 Jul 8. Eur J Nucl Med Mol Imaging. 2017. PMID: 28689281 Free PMC article. Clinical Trial.

8

Application of novel quantitative techniques for fluorodeoxyglucose positron emission tomography/computed tomography in patients with non-small-cell lung cancer.

Wang D, Koh ES, Descallar J, Pramana A, Vinod SK, Ho Shon I. Wang D, et al. Asia Pac J Clin Oncol. 2016 Dec;12(4):349-358. doi: 10.1111/ajco.12587. Epub 2016 Aug 23. Asia Pac J Clin Oncol. 2016. PMID: 27550522

9

Outcomes of Modestly Hypofractionated Radiation for Lung Tumors: Pre- and Mid-Treatment Positron Emission Tomography-Computed Tomography Metrics as Prognostic Factors.

Harris JP, Chang-Halpenny CN, Maxim PG, Quon A, Graves EE, Diehn M, Loo BW Jr. Harris JP, et al. Clin Lung Cancer. 2015 Nov;16(6):475-85. doi: 10.1016/j.cllc.2015.01.007. Epub 2015 Jan 31. Clin Lung Cancer. 2015. PMID: 25770888

10

FDG PET/CT texture analysis for predicting the outcome of lung cancer treated by stereotactic body radiation therapy.

Lovinfosse P, Janvary ZL, Coucke P, Jodogne S, Bernard C, Hatt M, Visvikis D, Jansen N, Duysinx B, Hustinx R. Lovinfosse P, et al. Eur J Nucl Med Mol Imaging. 2016 Jul;43(8):1453-60. doi: 10.1007/s00259-016-3314-8. Epub 2016 Jan 30. Eur J Nucl Med Mol Imaging. 2016. PMID: 26830299

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

143 results

Results by year